Cranberry and urinary tract infections

Area of Science:

• Urology
• Infectious Diseases
• Pharmacology

Background:

• Urinary tract infections (UTIs) are common, particularly in women, with recurrent episodes affecting up to one-third.
• Traditional prevention involves low-dose antimicrobials, but interest in non-antimicrobial strategies like cranberry is growing.
• Cranberry's potential mechanism involves inhibiting bacterial adhesion to the uroepithelium.

Purpose of the Study:

• To evaluate the efficacy of cranberry products in the prevention of recurrent urinary tract infections (UTIs).
• To review the evidence for cranberry's mechanism of action and its limitations in clinical application.

Main Methods:

• Review of in vitro, animal, and human clinical studies on cranberry for UTI prevention.
• Analysis of meta-analyses and systematic reviews, including findings from the Cochrane Collaboration.
• Assessment of cranberry product standardization, dosage, formulation, and adverse events.

Main Results:

• Cranberry shows in vitro and animal efficacy by inhibiting uropathogen adhesion, particularly E. coli.
• Meta-analyses suggest a modest (approx. 35%) reduction in UTI recurrence rates in young to middle-aged women.
• Efficacy in other populations (elderly, pediatric, catheterized) is questionable, with high withdrawal rates and potential adverse effects.

Conclusions:

• Cranberry may offer a potential prophylactic strategy for recurrent UTIs in certain women, primarily through anti-adhesion properties.
• Significant challenges remain regarding product standardization, optimal dosage, and formulation, hindering consistent recommendations.
• Despite some supporting evidence, current data heterogeneity prevents a definitive recommendation for cranberry prophylaxis of recurrent UTIs.